VMNIX vs. IMMX
Compare and contrast key facts about Vanguard Market Neutral Fund Institutional Shares (VMNIX) and Immix Biopharma, Inc. (IMMX).
VMNIX is managed by Vanguard. It was launched on Oct 19, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VMNIX or IMMX.
Performance
VMNIX vs. IMMX - Performance Comparison
Returns By Period
In the year-to-date period, VMNIX achieves a 5.98% return, which is significantly higher than IMMX's -74.13% return.
VMNIX
5.98%
-1.62%
2.20%
6.81%
7.83%
3.31%
IMMX
-74.13%
9.82%
-20.44%
-59.32%
N/A
N/A
Key characteristics
| VMNIX | IMMX | |
|---|---|---|
| Sharpe Ratio | 1.09 | -0.59 |
| Sortino Ratio | 1.62 | -0.64 |
| Omega Ratio | 1.19 | 0.93 |
| Calmar Ratio | 2.07 | -0.73 |
| Martin Ratio | 4.92 | -0.93 |
| Ulcer Index | 1.38% | 63.60% |
| Daily Std Dev | 6.23% | 101.14% |
| Max Drawdown | -25.29% | -88.89% |
| Current Drawdown | -3.19% | -75.38% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between VMNIX and IMMX is 0.01, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
VMNIX vs. IMMX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard Market Neutral Fund Institutional Shares (VMNIX) and Immix Biopharma, Inc. (IMMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VMNIX vs. IMMX - Dividend Comparison
VMNIX's dividend yield for the trailing twelve months is around 4.90%, while IMMX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VMNIX Vanguard Market Neutral Fund Institutional Shares | 4.90% | 5.15% | 0.78% | 0.20% | 0.85% | 3.22% | 1.00% | 1.16% | 0.45% | 0.10% | 0.00% | 0.04% |
IMMX Immix Biopharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
VMNIX vs. IMMX - Drawdown Comparison
The maximum VMNIX drawdown since its inception was -25.29%, smaller than the maximum IMMX drawdown of -88.89%. Use the drawdown chart below to compare losses from any high point for VMNIX and IMMX. For additional features, visit the drawdowns tool.
Volatility
VMNIX vs. IMMX - Volatility Comparison
The current volatility for Vanguard Market Neutral Fund Institutional Shares (VMNIX) is 2.22%, while Immix Biopharma, Inc. (IMMX) has a volatility of 22.36%. This indicates that VMNIX experiences smaller price fluctuations and is considered to be less risky than IMMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.